FAQ

Duolip

Known as: Merckle brand of etofyllinclofibrate 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-1995
051019801995

Related topics

Related topics

1 relation

Broader (1)

etofylline clofibrate

Related mentions per year

Related mentions per year

1980-2012
19801990200020102020
Duolip
etofylline clofibrate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
[Use of etofyllinclofibrate (Duolip Forte) in combined hyperlipidemia].
BACKGROUND Duolip forte (ethophyllinclofibrate) is a lipid lowering drug, the effect of which was not yet adequately verified in… (More)
Is this relevant?
1994
1994
[Relation between hypertriacylglycerolemia and the action of insulin in type 2 diabetes mellitus].
BACKGROUND Insulin resistance and hypertriacylglycerolaemia are part of the X syndrome and are supposed to be interrelated. The… (More)
Is this relevant?
1993
1993
[Duolip Forte--experience during a 6-month period of administration].
Duolip forte (ethophylline clofibrate, tablets à 500 mg) produced by Merckle Austria was administered to 20 patients with… (More)
Is this relevant?
1986
1986
Effect of etofylline clofibrate on experimental thrombus formation and prostacyclin activation.
1-(7-Theophyllinyl)-2-ethyl-[2-(p-chlorophenoxy)-isobutyrate] (etofylline clofibrate, theofibrate, Duolip) was shown to possess… (More)
Is this relevant?
1983
1983
[Modification of serum uric acid concentration under long-term therapy with the lipid-regulating drug Duolip].
During an 8-months treatment period the effect of Duolip on serum uric acid in 112 patients with hyperlipidemia was studied. In… (More)
Is this relevant?
1980
1980
Biopharmaceutic evaluation of etofylline clofibrate and its drug formulation.
The biopharmaceutic criteria of Duolip and its active principle, 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2… (More)
Is this relevant?
Review
1980
Review
1980
[On the uricosuric activity of etofylline clofibrate (author's transl)].
In a review study including altogether 5 clinical trials with a total of 221 hyperlipidaemic patients the influence of 1… (More)
Is this relevant?
1980
1980
Hypolipaemic activity of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate) and its analogues in normolipaemic rats.
The hypolipaemic potential of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate, ML… (More)
Is this relevant?
1980
1980
[On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
Efficacy and tolerance of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate, Duolip… (More)
Is this relevant?
1980
1980
[Metabolism and pharmacokinetics of etofylline clofibrate, new antilipemic].
Upon investigations on metabolism and pharmacokinetics of 1-(theophyllin-7-yl)-ethyl-2-[2-(chlorophenoxy)-2-methylpropionate… (More)
Is this relevant?